Rotem Eran's Form 4 filing
CollPlant Biotechnologies Ltd (CLGN) · filed Sep 8, 2026
- Accession no.
- 0001213900-26-098038
- Filed
- Sep 8, 2026, 4:05 PM ET
- Trade date
- Sep 3, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rotem EranCIK 0001423145 | Officer (Deputy CEO and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Ordinary Shares | AGrant or awardAcquired | +510,372 | $0.00 | $0 | 516,372 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.